327
Views
32
CrossRef citations to date
0
Altmetric
Original Research

Impact of reducing dosing frequency on adherence to oral therapies: a literature review and meta-analysis

, , , , &
Pages 419-434 | Published online: 20 May 2013

References

  • World Health OrganizationFailure to take prescribed medicine for chronic diseases is a massive, world-wide problem [news release] Available from: http://www.who.int/mediacentre/news/releases/2003/pr54/enAccessed February 12, 2013
  • JackeviciusCAMamdaniMTuJVAdherence with statin therapy in elderly patients with and without acute coronary syndromesJAMA2002288446246712132976
  • Dunbar-JacobJErlenJASchlenkEARyanCMSereikaSMDoswellWMAdherence in chronic diseaseAnnu Rev Nurs Res200018489010918932
  • StuartBBriesacherBMedication decisions – right and wrongMed Care Res Rev200259212314512053819
  • KyngasHLahdenperaTCompliance of patients with hypertension and associated factorsJ Adv Nurs199929483283910215974
  • StangPSuppapanayaNHogueSLParkDRigneyUPersistence with once-daily versus twice-daily bupropion for the treatment of depression in a large managed-care populationAm J Ther200714324124617515697
  • DeziiCMKawabataHTranMEffects of once-daily and twice-daily dosing on adherence with prescribed glipizide oral therapy for type 2 diabetesSouth Med J2002951687111827247
  • CarrieriMPLeportCProtopopescuCFactors associated with nonadherence to highly active antiretroviral therapy: a 5-year follow-up analysis with correction for the bias induced by missing data in the treatment maintenance phaseJ Acquir Immune Defic Syndr200641447748516652057
  • SidhuMLeesLWarnerJFive-year budget impact analysis of once-daily versus twice-daily tacrolimus, in patients undergoing renal transplant in the United Kingdom [abstract]Value Health201013A170
  • SongXSanderSVarkerHAminAPatterns and predictors of persistence of warfarin and other commonly-utilized chronic medications among patients with atrial fibrillation [abstract]Value Health201013A170
  • DiMatteoMRVariations in patients’ adherence to medical recommendations: a quantitative review of 50 years of researchMed Care200442320020915076819
  • CramerJARoyABurrellAMedication compliance and persistence: terminology and definitionsValue Health2008111444718237359
  • ArnstenJHGelfandJMSingerDEDeterminants of compliance with anticoagulation: a case-control studyAm J Med1997103111179236480
  • OsterbergLBlaschkeTAdherence to medicationN Engl J Med2005353548749716079372
  • ShiLHodgesMYurginNBoyeKSImpact of dose frequency on compliance and health outcomes: a literature review (1966–2006)Expert Rev Pharmacoecon Outcomes Res20077218720220528445
  • ClaxtonAJCramerJPierceCA systematic review of the associations between dose regimens and medication complianceClin Ther20012381296131011558866
  • RichterAAntonSEKochPDennettSLThe impact of reducing dose frequency on health outcomesClin Ther2003258:23072335 discussion 230614512137
  • IskedjianMEinarsonTRMacKeiganLDRelationship between daily dose frequency and adherence to antihypertensive pharmacotherapy: evidence from a meta-analysisClin Ther200224230231611911560
  • ParientiJJBangsbergDRVerdonRGardnerEMBetter adherence with once-daily antiretroviral regimens: a meta-analysisClin Infect Dis200948448448819140758
  • ColemanCILimoneBSobierajDMDosing frequency and medication adherence in chronic diseaseJ Manag Care Pharm201218752753922971206
  • MoherDLiberatiATetzlaffJAltmanDGPreferred reporting items for systematic reviews and meta-analyses: the PRISMA statementAnn Intern Med20091514:264269W26419622511
  • DerSimonianRLairdNMeta-analysis in clinical trialsControl Clin Trials1986731771883802833
  • HigginsJPThompsonSGDeeksJJAltmanDGMeasuring inconsistency in meta-analysesBMJ2003327741455756012958120
  • BerlinJAAntmanEMAdvantages and limitations of metaanalytic regressions of clinical trials dataOnline J Curr Clin Trials641994 Doc No 134
  • NegredoEMoltoJMunoz-MorenoJASafety and efficacy of once-daily didanosine, tenofovir and nevirapine as a simplification antiretroviral approachAntivir Ther20049333534215259896
  • KaneSHuoDMagnantiKA pilot feasibility study of once daily versus conventional dosing mesalamine for maintenance of ulcerative colitisClin Gastroenterol Hepatol20031317017315017487
  • WinklerATeuscherAUMuellerBDiemPMonotoring adherence to prescribed medication in type 2 diabetic patients treated with sulfonylureasSwiss Med Wkly200213227–2837938512428192
  • HawthorneABStensonRGillespieDOnce daily mesalazine as maintenance therapy for ulcerative colitis (UC): a one-year single-blind randomized trial [abstract]Gastroenterology2011140SupplS65
  • BairdMGBentley-TaylorMMCarruthersSGA study of efficacy, tolerance and compliance of once-daily versus twice-daily metoprolol (Betaloc) in hypertension. Betaloc Compliance Canadian Cooperative Study GroupClin Invest Med198472951026380858
  • AndrejakMGenesNVaurLPonceletPClersonPCarreAElectronic pill-boxes in the evaluation of antihypertensive treatment compliance: comparison of once daily versus twice daily regimenAm J Hypertens200013218419010701819
  • KardasPOnce-daily dosage secures better compliance with antibiotic therapy of respiratory tract infections than twice daily dosageJ Appl Res200332201206
  • KardasPComparison of patient compliance with once-daily and twice-daily antibiotic regimens in respiratory tract infections: results of a randomized trialJ Antimicrob Chemother200759353153617289766
  • PullarTBirtwellAJWilesPGHayAFeelyMPUse of a pharmacologic indicator to compare compliance with tablets prescribed to be taken once, twice, or three times dailyClin Pharmacol Ther19884455405453180635
  • MaroEELwakatareJMedication compliance among Tanzanian hypertensivesEast Afr Med J19977495395429487426
  • Echarri MartinezLERodriguez GonzalezCGCastillo RomeraIEvolution of adherence to antiretroviral treatment in a Spanish hospital during 2001, 2005, and 2008Lat Am J Pharm20113011731178
  • McLaughlinTHogueSLStangPEOnce-daily bupropion associated with improved patient adherence compared with twice-daily bupropion in treatment of depressionAm J Ther200714222122517414593
  • HessGBhandaryDFonsecaEAdherence to medications with once-a-day (qd) and twice-a-day (bid) dosing formulations in acute coronary syndrome (ACS) patients [abstract]Value Health201114A44
  • MoyleGThe Assessing Patients’ Preferred Treatments (APPT-1) studyInt J STD AIDS200314Suppl 1343614617402
  • GrangerALFehnelSEHogueSLBennettLEdinHMAn assessment of patient preference and adherence to treatment with Wellbutrin SR: a web-based surveyJ Affect Disord2006902–321722116360216
  • TurkiAKSulaimanSASAdherence to antihypertensive therapy in general hospital of Penang: does daily dose frequency matter?Jordan J Pharm Sci20092167175
  • BeggCBMazumdarMOperating characteristics of a rank correlation test for publication biasBiometrics1994504108811017786990
  • EggerMDavey SmithGSchneiderMMinderCBias in meta-analysis detected by a simple, graphical testBMJ199731571096296349310563
  • CelisHStaessenJFagardRThijsLAmeryADoes isradipine modified release 5 mg once daily reduce blood pressure for 24 hours?J Cardiovasc Pharmacol19932223003047692173
  • GirvinBMcDermottBJJohnstonGDA comparison of enalapril 20 mg once daily versus 10 mg twice daily in terms of blood pressure lowering and patient complianceJ Hypertens199917111627163110608477
  • BoisselJPMeillardOPerrin-FayolleEComparison between a bid and a tid regimen: improved compliance with no improved antihypertensive effect. The EOL Research GroupEur J Clin Pharmacol1996501–263678739813
  • BrownREKendallMJHalpernMTCost analysis of once-daily ISMN versus twice-daily ISMN or transdermal patch for nitrate prophylaxisJ Clin Pharm Ther199722167769292406
  • KardasPCompliance, clinical outcome, and quality of life of patients with stable angina pectoris receiving once-daily betaxolol versus twice daily metoprolol: a randomized controlled trialVasc Health Risk Manag20073223524217580734
  • DoeschAOMuellerSKonstandinMIncreased adherence after switch from twice daily calcineurin inhibitor based treatment to once daily modified released tacrolimus in heart transplantation: a pre-experimental studyTransplant Proc201042104238424221168673
  • BaeJPAndersonJZagarAThe effects of dosing complexity on adherence with prescription medications commonly used for cardiovascular patients [abstract]Value Health2010A360
  • StangPYoungSHogueSBetter patient persistence with once-daily bupropion compared with twice-daily bupropionAm J Ther2007141202417303971
  • CramerJAMattsonRHPreveyMLScheyerRDOuelletteVLHow often is medication taken as prescribed? A novel assessment techniqueJAMA198926122327332772716163
  • PfeifferPNGanoczyDValensteinMDosing frequency and adherence to antipsychotic medicationsPsychiatr Serv200859101207121018832509
  • MullenersWMWhitmarshTESteinerTJNoncompliance may render migraine prophylaxis useless, but once-daily regimens are betterCephalalgia199818152569601625
  • CarlosFRamirezJGalindo-SuarezRMDuenasHPDB33 Economic evaluation of three first-line medications in painful diabetic peripheral neuropathy in MexicoValue in Health2010133A60
  • KardasPThe DIACOM study (effect of DosIng frequency of oral Antidiabetic agents on the COMpliance and biochemical control of type 2 diabetes)Diabetes Obes Metab20057672272816219016
  • CharpentierGFleuryFDubrocaIVaurLClersonPElectronic pill-boxes in the evaluation of oral hypoglycemic agent complianceDiabetes Metab200531218919515959425
  • StoneVEHoganJWSchumanPAntiretroviral regimen complexity, self-reported adherence, and HIV patients’ understanding of their regimens: survey of women in the her studyJ Acquir Immune Defic Syndr200128212413111588505
  • AbellanJGarroteMPulidoFRubioRCostaJREvaluation of adherence to a triple antiretroviral therapy in HIV-positive patientsEur J Intern Med1999104202205
  • SpiritusEMChangRJZhangJXCost savings of clarithromycin compared with erythromycin or cefaclor in the treatment of lower respiratory tract infection: Results of a randomized, multicenter studyAm J Manag Care19984Suppl 11S562S570
  • RazRElchananGColodnerRPenicillin V twice daily vs four times daily in the treatment of streptococcal pharyngitisInfect Dis Clin Pract1995415054
  • AbecassisMMSeifeldinRRiordanMEPatient outcomes and economics of once-daily tacrolimus in renal transplant patients: results of a modeling analysisTransplant Proc20084051443144518589126
  • EberlinMBKramerIEvaluation of medication compliance of liver transplant patients switched from a twice-daily to a once-daily tacrolimus-based regimen [abstract]Pharm World Sci20103267067120717844
  • LachaineJBeaucheminCYenLHodgkinsPMedication adherence and persistence in the treatment of ulcerative colitis analyses with the RAMQ database [abstract]Can J Gastroenterol201125Suppl A Abstract A072
  • ConnollyMPNielsenSKCurrieCJPooleCDTravisSPAn economic evaluation comparing once daily with twice daily mesalazine for maintaining remission based on results from a randomised controlled clinical trialJ Crohns Colitis200931323721172245
  • FischerRGCompliance-oriented prescribing: simplifying drug regimensJ Fam Pract19801034274356986449
  • BaeJPDobeshPPKlepserDGAdherence and dosing frequency of common medications for cardiovascular patientsAm J Manag Care201218313914622435907
  • GouldEMittyEMedication adherence is a partnership, medication compliance is notGeriatr Nurs201031429029820682408
  • UrquhartJAscertaining how much compliance is enough with outpatient antibiotic regimensPostgrad Med J199268Suppl 3S49S58 discussion S591287619
  • PetersenMLWangYvan der LaanMJGuzmanDRileyEBangsbergDRPillbox organizers are associated with improved adherence to HIV antiretroviral therapy and viral suppression: a marginal structural model analysisClin Infect Dis200745790891517806060
  • SimoniJMPearsonCRPantaloneDWMarksGCrepazNEfficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load. A meta-analytic review of randomized controlled trialsJ Acquir Immune Defic Syndr200643Suppl 1S23S3517133201